Shay Capital LLC Biovie Inc. Transaction History

Shay Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.74 - $5.65 $64,568 - $133,142	-23,565 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.41 - $6.99 $2,892 - $4,585	656 Added 2.86%	23,565 $106,000
Q3 2021 Nov 15, 2021	BUY	$6.69 - $16.93 $153,261 - $387,849	22,909 New	22,909 $153,000
Q2 2021 Aug 13, 2021	SELL	$10.57 - $21.61 $215,099 - $439,763	-20,350 Closed	0 $0
Q1 2021 Aug 13, 2021	SELL	$14.35 - $44.81 $53,898 - $168,306	-3,756 Reduced 15.58%	20,350 $394,000
Q4 2020 Aug 13, 2021	BUY	$7.85 - $17.32 $189,232 - $417,515	24,106 New	24,106 $418,000

340K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $86.3M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.